The global neuro-navigation systems market size was valued at USD 2.4 billion in 2021 and is projected to witness a compound annual growth rate (CAGR) of 7.77% from 2022 to 2030. Neuro-navigation also called frameless stereotactic surgery which involves performing real-time intraoperative guidance during spinal/brain injuries. This system enhances safety and accuracy during neurosurgical procedures and helps surgeons achieve surgical targets without the need for external. Neuro-navigation systems are primarily used in brain surgery to limit the size of the cranial opening or craniotomy, and help remove deep brain lesions. It also assists psychiatrists to precisely target rTMS (Transcranial Magnetic Stimulation). Such factors are likely to drive the demand for the neuro-navigation systems market in the near future.
Growing incidence of neurological disorders such as cancer, benign tumors, and stroke as well as rising adoption of minimally invasive surgical procedures are the key growth drivers for the global neuro-navigation systems market. Furthermore, the demand for neuro-navigation systems is expected to grow as the number of neurosurgical procedures being performed worldwide increases. For instance, as per the American Cancer Society, in 2022, approximately 25,050 malignant tumors of the brain or spinal cord (14,170 in men and 10,880 in women) will be diagnosed in the U.S. and around 18,280 people will die from the same illness. Similarly, as per the World Cancer Research Fund International data report 2020, around 308,102 new cases of brain and CNS cancer were diagnosed and 251,329 cancer-related deaths occurred in 2020 worldwide. Thus, the rising patient pool suffering from brain tumors and related conditions leading to brain metastasis is expected to propel the demand for neuro-navigation systems during the forecast period.
The outbreak of COVID-19 in the year 2020, has negatively impacted the neuro-navigation systems market by directly affecting the demand & production, creating a disruption in the supply chain and increasing the financial burden on firms. Neurocare and neurosurgeons have been adversely impacted by the pandemic. To reduce the spread of the coronavirus, brain surgeries have frequently been postponed or even canceled during this timeframe. In worst-affected nations, such as the U.S., Russia, India, Brazil, France, the UK, Italy, and Spain, neurosurgical operations fell by 55%. However, according to a research study “COVID-19 and Hospital: A review” published in Elsevier journal (International Hemorrhagic Hospital Association) (Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms and there were several cases related to ischemic & hemorrhagic infarction. These findings also suggest that COVID-19 might enhance sales in the neurology industry, especially for neuro-navigation systems. Thus, these factors are expected to create lucrative opportunities for the market to grow in the near future, providing profitable opportunities for key players post COVID-19.
Furthermore, a case study published in the Journal of Neurology, Neurosurgery & Psychiatry (BMJ Publishing Group Ltd.) has projected a possible link between COVID-19 infection and acute necrotizing encephalitis. Thus, these factors are expected to create lucrative opportunities for the market to grow in the near future, providing profitable opportunities for key players post COVID-19.
The rising adoption of minimally invasive neurosurgeries is majorly driving the neuro-navigation system market growth. Patients prefer minimally invasive surgeries because it reduces the recovery time and surgeons use a variety of tools to reduce trauma to body tissue during surgeries. As this technique minimizes the risk of surgery and involves smaller incisions and smaller instruments compared to the traditional surgery. This procedure involves numerous benefit such as it minimizes incisions as well as allow surgeons to cosmetically hide scars. Minimally invasive surgeries are also used in applications such as brain tumors as well as a benign brain tumor. Due to the less invasive nature of these devices, patients recover faster and surgeons have more time span to dedicate to other surgeries. Thus, while performing neurosurgeries, surgeons recommend minimally invasive surgeries to patients, owing to its advantages as compared to the traditional method of treatment leading to the increased demand of neuro-navigation systems.
Furthermore, several initiatives are being undertaken by various government and private organizations for awareness related to early brain disorders diagnosis and treatment. For instance, the month of May is being recognized as “Brain Tumor Awareness Month”. A campaign launched by the National Brain Tumor Society- “It’s Your Fight, It’s Our Fight” aims at educating and engaging the people through activities that can lead to increased awareness and cures for brain tumors. Similarly, the HeadSmart national awareness campaign funded by the Brain Tumor Charity aims to reduce brain childhood brain tumors and cancer diagnosis times to 4 weeks or less. This growing awareness among people regarding the treatment and diagnosis is likely to boost the neuro-navigation systems market growth during the forecast period.
The U.S. dominated the overall neuro-navigation systems market with the highest shares of 85.53% in 2021. According to the National Brain Tumor Society, in the U.S. around 700,000 people are surviving brain tumor. This includes 69.8% of benign tumors, and 30.2% malignant tumors. It is estimated that in 2020 approximately 87,240 people were diagnosed with a primary brain tumor. In addition, over 4,000 brain and spinal cord tumors are diagnosed each year in children and teens. Thus, the increasing prevalence of brain cancer is anticipated to boost market growth during the forecast period. Moreover, rapid technological advancements, coupled with the frequent launch of new & innovative products, are among the key factors fueling the market growth during the forecast period. Furthermore, the presence of well-defined regulatory guidelines and reimbursement policies for neurological procedures is boosting revenue generation in the country. The CMS offers favorable healthcare insurance policies for various neurological procedures, which may increase the number of patients opting for such services.
Additionally, the increasing number of cases of neurological disorders including brain tumors in developed and developing countries has driven the launch of technologically advanced products in the market. Market players are taking constant efforts to introduce technologically advanced products in the market. For instance, in December 2021, ClaroNav Kolahi (ClaroNav) received regulatory approval from the National Medical Products Administration (NMPA) to market and sell its Navient cranial model in China. Previously, the company had received NMPA approval for its Navient ENT model. Similarly, in March 2021, 7D Surgical announced the launch of its FLASH navigation system in Germany and Switzerland. Such developments, therefore, are anticipated to propel the market growth over the forecast period.
In 2021, the optical system segment dominated the market and accounted for the largest revenue share of 57.8%. This growth is attributed to the ease of use, better line of sight, and affordability of the technology as compared to electromagnetic navigation. Moreover, this system has boosted technical procedures in surgery and paved the way for complex neurological procedures. Moreover, it is built on the principle of stereo vision with high precision. Such advantages associated with the technology can be attributed to the overall segment growth.
In addition, the optical system segment is anticipated to witness the fastest CAGR of 7.8% during the forecast period. Optical systems provide better results as compared to electromagnetic surgical navigation systems. They are considered the industry standard for neurosurgeries and are capable of tracking a large number of tools simultaneously. These systems find application in medical procedures, which require very high precision and demand major access paths, such as operations on the lateral skull base. They are unaffected by the presence of metallic objects and electromagnetic fields in the surrounding environment. Thus, such advantages associated with the technology can be attributed to segment growth.
The neurosurgery segment held the largest revenue share of 30.4% in 2021. Neurosurgery involves the treatment of brain cancer and various disorders of the Central Nervous System (CNS) that demand precise diagnosis and accurate procedures, possible with the aid of neuro-navigation systems. An upsurge in the number of individuals suffering from brain tumors and cancer leading to brain metastasis is likely to boost demand for neuro-navigation systems. Navigation offers accurate localization of vital anatomic structures, such as cranial nerves or carotid arteries, particularly if they are deep in the tumor. Furthermore, it provides a real-time display of a tracked instrument thereby providing increased anatomic appreciation and enhancing the confidence of surgeons and their perception of safety. The aforementioned benefits are expected to contribute towards the steady growth of this segment.
However, the others segment which includes catheter placement, radiation therapy, DBS Lead placement, biopsy, and resection is expected to witness the fastest CAGR of 8.4% during the forecast period. The prevalence of major neurological disorders is increasing owing to the rising geriatric population. According to the American Cancer Society, brain tumor is considered the 8th most common type of cancer and the 3rd most common cause of cancer deaths in the age group of 40 and above. As the population is aging and growing, the demand for treatment is expected to increase significantly, hence positively impacting the growth of the neuro-navigation systems market. These systems are majorly used in brain surgeries that help to limit the size of skull openings or craniotomy and remove brain lesions. Furthermore, various government and independent organizations, such as American Brain Tumor Association, WHO, and International Brain Tumor Alliance, are working toward supporting the availability of treatment and conducting research on a novel cure for the disease. Thereby, augmenting the segment growth over the forecast period.
In 2021, the hospital segment dominated the neuro-navigation systems market with a share of 51.8%. Hospitals are widely preferred by patients in comparison to neurology clinics owing to improving health care facilities and the availability of advanced equipment. In addition, patients’ inclination towards the hospital since the patient gets treatment within eight hours onset of his symptoms is fueling segment growth. Increasing incidence of brain cancer and related disorders are expected to boost segment growth. Technologically advanced medical devices are being used extensively used in hospitals to improve Point-of-Care (PoC). These devices not only simplify the treatment procedures but also enable faster and more accurate results. Owing to these factors the segment is expected to continue witnessing steady growth in the near future.
However, the Ambulatory surgical centers (ASCs) segment is expected to witness the highest CAGR of 8.3% during the forecast period. Since, more than half of the outpatient surgeries are performed in ASCs, including brain biopsy and tumor removal surgical procedures. In addition, shorter waiting time offered by ASCs to patients is expected to drive the segment at a significant rate during the forecast period. Further, with increasing demand for minimally invasive surgical procedures, the introduction of technologically advanced products is expected to boost the neuro-navigation systems market. For instance, in May 2019, StimGuide TMS navigation system was launched by MagStim, to provide consistent and precise coil positioning while performing depressive disorder treatments. Such advancements are expected to boost segment growth over the forecast period.
North America dominated the neuro-navigation systems market and accounted for the largest revenue share of 45.4% in 2021. The presence of key participants, huge investments by governments for development of innovative medical devices, and early introduction of novel medical devices are supplementing the growth of market in the region. Also, presence of extensive public & private funding initiatives, especially in the U.S., to create awareness regarding advanced devices. These initiatives, including the U.S. Affordable Care Act (ACA), focus on reducing the cost of medical devices. Furthermore, rising preference for ambulatory surgery centers and along with growing procedure volumes, imposing a burden on procedure volumes at hospitals is the primary growth factor. A quality-driven healthcare model coupled with a shifting focus to ambulatory surgeries in a cost-curbing environment is driving the regional demand.
However, Asia Pacific is estimated to witness the highest growth of CAGR of 8.4% in the market over the forecast period. The highest growth rate of the regional market can be attributed to developing economies, an increasingly aging population, and growing healthcare awareness. The geriatric population is more susceptible to neurological disorders thereby presenting a huge target population in the region, with Japan, China, and India being the major regional contributors. In addition, high-untapped opportunities, rising interest of companies to expand their presence in this region, and continuous R&D activities by the key market players for better innovative products are expected to fuel the growth. For instance, in April 2021, Medtronic launched the largest R&D center outside of the U.S. in India. The expanded Engineering and Innovation Center makes India a key hub for the company’s global R&D effort.
The market leaders operating in the market are focusing on introducing innovative devices and solutions to offer increased comfort to patients with neurological disorders and improve their quality of life. Advancements in technology such as improved accuracy due to improved software and registration processes, as well as the less complicated framework is expected to propel the growth of the neuro-navigation systems market. For instance, in May 2021, ClearPoint Neuro, Inc., announced the first human cases of the SmartFrame Array Neuro-navigation system and software. This system is designed to streamline workflows and reduce procedure time in both the MRI suite and in the operating room.
Similarly, mergers, acquisitions, partnerships, and strengthening of the distribution network are the key strategies adopted by the market players to fuel their growth and expansion goals. For instance, in April 2021, Medtronic announced the StealthStation S8 and the StealthStation ENT surgical navigation systems that are now approved for sale in Canada. This system provides enhanced visualization to surgeons and helps to precisely locate anatomical structures in either open or minimally invasive procedures like skull, spinal cord, and sinus cavities. Some of the prominent players in the neuro-navigation systems market include:
Soterix Medical Inc.
Zimmer Biomet Holding Inc.
Northern Digital Inc.
Market size value in 2022
USD 2.6 billion
Revenue forecast in 2030
USD 4.8 billion
CAGR of 7.77% from 2022 to 2030
Base year for estimation
2018 - 2020
2022 - 2030
Revenue in USD million and CAGR from 2022 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Technology, application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; France; Italy; The Netherlands; Spain; Sweden; Japan; China; India; South Korea; Taiwan; Australia; Vietnam; Brazil; Mexico; South Africa; Saudi Arabia
Key companies profiled
Northern Digital Inc.; ClaroNav; Medtronic; Stryker; BrainLAB AG; Synaptive Medical; Soterix Medical Inc.; Stryker; Nexstim Plc; 7D Surgical; Zimmer Biomet Holding Inc.; Parsis Co.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global neuro-navigation systems market report on the basis of technology, application, end-use, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Application Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Ambulatory Surgical Centers (ASCs)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. The global neuro-navigation systems market size was estimated at USD 2.4 billion in 2021 and is expected to reach USD 2.6 billion in 2022.
b. The global neuro-navigation systems market is expected to grow at a compound annual growth rate of 7.77% from 2022 to 2030 to reach USD 4.8 billion by 2030.
b. North America dominated the neuro-navigation systems market with a share of 45.41% in 2021. This is attributable to various factors such as well-established healthcare infrastructure, high prevalence of neurological disorders, and rapid adoption of technologically advanced products coupled with constant research and development initiatives in the region.
b. Some key players operating in the neuro-navigation systems market include Northern Digital Inc., ClaroNav, Medtronic, Stryker, BrainLAB AG, Synaptive Medical, Soterix Medical Inc., Stryker, Nexstim Plc, 7D Surgical, Zimmer Biomet Holding Inc., and Parsis Co. and other players
b. Key factors that are driving the neuro-navigation systems market growth include the growing incidence of neurological disorders such as cancer, benign tumors, and stroke as well as the rising adoption of minimally invasive surgical procedures. Furthermore, the demand for neuro-navigation systems is expected to grow as the number of neurosurgical procedures being performed worldwide increases
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."